BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodríguez-fernández K, Mangas-sanjuán V, Merino-sanjuán M, Martorell-calatayud A, Mateu-puchades A, Climente-martí M, Gras-colomer E. Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis. Pharmaceutics 2022;14:654. [DOI: 10.3390/pharmaceutics14030654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Qiao J, Jin H, Chen B, He Z, Wang G, Ni X, Wang M, Xia M, Li B, Chen R, Hu P. Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis. Front Pharmacol 2022;13:966176. [DOI: 10.3389/fphar.2022.966176] [Reference Citation Analysis]
2 Balak DMW, Lambert J. Weighing in on weight-based secukinumab dosing for psoriasis. Br J Dermatol 2022. [PMID: 35575459 DOI: 10.1111/bjd.21607] [Reference Citation Analysis]